Assignee
GENFLEET THERAPEUTICS SHANGHAI INC
CN·5 granted patents·18 pending applications·7 citations·filing 2017–2025
Top patents by PatentIndex Score
23 records- 0186US12054497B2Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 6, 2024·3 cites·20 claims
- 0284US10952999B2Inhibitor of cyclin-dependent kinase CDK9GENFLEET THERAPEUTICS SHANGHAI INC·Filed 2018·Granted Mar 23, 2021·3 cites·10 claims
- 0376US10548883B2Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitorGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2017·Granted Feb 4, 2020·1 cites·19 claims
- 0474US2026015347A1Polymorph of cdk9 inhibitor and preparation method for polymorph and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2025·Application pending·0 cites
- 0563US12384774B2Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 12, 2025·0 cites·21 claims
- 0659US2024352040A1Crystal form of ripk1 inhibitor, acid salt thereof, and crystal form of acid salt thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 0758US2025221989A1Pharmaceutical composition, use thereof, and method for treating cancerGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 0858US2024158417A1Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 0957US2024294523A1Heterocyclic lactam compound, and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1056US2025051333A1Polymorph of kras inhibitor, preparation method therefor, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1156US2026097032A1Pharmaceutical composition, and preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 1255US2024270758A1Pyridino-or pyrimido-cyclic compound, preparation method therefor and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1353US2025186456A1Pyrimidine-fused cyclic compound and preparation method and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1451US2024174691A1Pyrimidine-fused cyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1549US11236112B2Crystal form and salt form of TGF-βRI inhibitor and preparation method thereforGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2018·Granted Feb 1, 2022·0 cites·16 claims
- 1649US2024360154A1Aroyl substituted tricyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 1749US2024182465A1Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1847US2023139111A1Dihydronaphthyridinone compound, and preparation method therefor and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 1946US2022363681A1Oxo six-membered cyclopyrimidine compound, preparation method and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2045US2023203060A1Fused tricyclic compound, pharmaceutical composition thereof, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 2145US2022235032A1Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2245US2022177462A1Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2342US2022251109A1Oxaazaquinazoline-7(8h)-ketone compound, preparation method therefor and pharmaceutical application thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENFLEET THERAPEUTICS SHANGHAI INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →